Association of

African American Arg72Pro Pro47Ser SNP TP53 medical disparity prostate cancer single nucleotide polymorphism

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
09 May 2023
Historique:
received: 13 04 2023
revised: 25 04 2023
accepted: 05 05 2023
medline: 27 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Growing evidence indicates the involvement of a genetic component in prostate cancer (CaP) susceptibility and clinical severity. Studies have reported the role of germline mutations and single nucleotide polymorphisms (SNPs) of

Identifiants

pubmed: 37239075
pii: biomedicines11051404
doi: 10.3390/biomedicines11051404
pmc: PMC10216554
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Center for Prostate Disease Research, Uniformed Services University Grant
ID : HU0001-10-2-0002
Organisme : DoD/PCRP Health Disparity Award
ID : W81XWH-13-2-0096

Références

Int J Mol Sci. 2019 Apr 12;20(8):
pubmed: 31013716
Biosci Rep. 2020 May 29;40(5):
pubmed: 32406493
Cell Cycle. 2008 Apr 1;7(7):848-52
pubmed: 18414047
Mol Vis. 2009 Sep 22;15:1939-44
pubmed: 19784392
Nature. 1992 Jul 2;358(6381):15-6
pubmed: 1614522
Arch Physiol Biochem. 2019 Jul;125(3):255-262
pubmed: 29560751
J Soc Gynecol Investig. 2004 May;11(4):232-6
pubmed: 15120697
Nature. 2021 Feb;590(7845):290-299
pubmed: 33568819
NPJ Breast Cancer. 2017 Feb 27;3:5
pubmed: 28649645
Prostate. 2001 Dec 1;49(4):263-6
pubmed: 11746272
Cell. 2015 May 21;161(5):1215-1228
pubmed: 26000489
Science. 1990 Nov 30;250(4985):1233-8
pubmed: 1978757
Curr Genomics. 2018 Aug;19(5):395-410
pubmed: 30065615
Dis Markers. 2013;35(6):701-10
pubmed: 24324286
Acta Oncol. 2006;45(5):602-9
pubmed: 16864176
Nature. 1990 Dec 20-27;348(6303):747-9
pubmed: 2259385
Nat Genet. 2003 Mar;33(3):357-65
pubmed: 12567188
Breast Cancer Res. 2007;9(3):R34
pubmed: 17537232
J Endocrinol Invest. 2008 Oct;31(10):893-9
pubmed: 19092295
JAMA Oncol. 2019 Apr 01;5(4):523-528
pubmed: 30730552
Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1684-8
pubmed: 12496062
Genet Mol Res. 2008 Feb 26;7(1):207-16
pubmed: 18393224
J Cell Mol Med. 2009 Mar;13(3):440-53
pubmed: 19379143
Future Oncol. 2020 May;16(14):923-937
pubmed: 32301350
J Biomed Sci. 2003 Jul-Aug;10(4):430-5
pubmed: 12824702
Cancer Res. 1988 Sep 15;48(18):5358-62
pubmed: 3409256
J Natl Compr Canc Netw. 2022 Dec;20(12):1288-1298
pubmed: 36509074
Asian Pac J Cancer Prev. 2020 Jul 01;21(7):2091-2098
pubmed: 32711437
Oncogene. 2021 Oct;40(41):5975-5983
pubmed: 34389799
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
BMC Med Genet. 2020 Oct 19;21(1):206
pubmed: 33076844
Br J Cancer. 2022 Jun;126(10):1366-1373
pubmed: 34923574
Cancer. 2020 Apr 15;126(8):1683-1690
pubmed: 31984482
Med Oncol. 2011 Sep;28(3):709-15
pubmed: 20443084
Nat Genet. 2021 Jan;53(1):65-75
pubmed: 33398198
Elife. 2020 Nov 10;9:
pubmed: 33170774
Clin Cancer Res. 2003 Oct 15;9(13):4860-4
pubmed: 14581358
Genet Mol Res. 2009 Jan 06;8(1):8-18
pubmed: 19224462
Prostate. 2005 Feb 15;62(3):243-52
pubmed: 15389726
Genet Mol Res. 2010 Apr 13;9(2):651-60
pubmed: 20449797
Cancers (Basel). 2022 Feb 06;14(3):
pubmed: 35159090
Nat Rev Cancer. 2009 Oct;9(10):701-13
pubmed: 19693097
Eur Urol Focus. 2018 Dec;4(6):818-824
pubmed: 28753864
Oncogene. 2007 Feb 26;26(9):1317-23
pubmed: 17322917
Eur Urol. 2022 Mar;81(3):243-250
pubmed: 34863587
Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6632-8
pubmed: 18006764
Biosci Trends. 2011;5(5):205-10
pubmed: 22101376
Asian J Androl. 2006 May;8(3):349-55
pubmed: 16625286
J Urol. 2013 Aug;190(2):419-26
pubmed: 23659877
Cell Death Differ. 2021 May;28(5):1477-1492
pubmed: 33257846
Cancer. 2008 Aug 15;113(4):799-807
pubmed: 18618574
Oncotarget. 2020 Apr 14;11(15):1321-1333
pubmed: 32341752
J Endocrinol Invest. 2015 Nov;38(11):1175-82
pubmed: 25935255
Tumour Biol. 2014 Oct;35(10):10309-17
pubmed: 25034526
Cancers (Basel). 2020 Sep 01;12(9):
pubmed: 32882831
Oncotarget. 2019 Jun 04;10(38):3581-3591
pubmed: 31217894
JAMA Netw Open. 2022 Jan 4;5(1):e2144027
pubmed: 35040965
Nat Rev Cancer. 2009 Feb;9(2):95-107
pubmed: 19165225
J Mol Cell Biol. 2019 Jul 19;11(7):578-585
pubmed: 31152665
Urol Oncol. 2011 May-Jun;29(3):291-4
pubmed: 19523860
Nat Genet. 2016 Nov;48(11):1443-1448
pubmed: 27694958
JAMA. 2018 May 8;319(18):1901-1913
pubmed: 29801017
Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2245-52
pubmed: 16172238
Asian Pac J Cancer Prev. 2020 Jun 01;21(6):1511-1519
pubmed: 32592343
Cancer Chemother Pharmacol. 2009 Jul;64(2):355-60
pubmed: 19052714
Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2217-24
pubmed: 15598783
Hum Genomics. 2015 Jan 07;9:1
pubmed: 25563503
Nature. 2000 Nov 16;408(6810):307-10
pubmed: 11099028
Sci Rep. 2022 Mar 30;12(1):5404
pubmed: 35354846
Genet Res (Camb). 2015 Apr 17;97:e7
pubmed: 25882871

Auteurs

Allison Duncan (A)

Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.
F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.

Darryl Nousome (D)

Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.

Randy Ricks (R)

Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.

Huai-Ching Kuo (HC)

Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.

Lakshmi Ravindranath (L)

Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.
Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, USA.

Albert Dobi (A)

Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.
Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, USA.

Jennifer Cullen (J)

Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.

Shiv Srivastava (S)

Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.

Gregory T Chesnut (GT)

Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.
Urology Service, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA.

Gyorgy Petrovics (G)

Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.
Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, USA.

Indu Kohaar (I)

Center for Prostate Disease Research, Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20817, USA.
Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., Bethesda, MD 20817, USA.

Classifications MeSH